Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :29033568
Publication Date : 2017/10/16

In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts.


Epidermal growth factor receptor (EGFR), upregulated in gastric cancer patients, is an oncogene of interest in the development of targeted cancer nanomedicines. This study demonstrates in silico modeling of monoclonal antibody cetuximab (CET MAb)-conjugated docetaxel (DOCT)-loaded poly(γ-glutamic acid) (γ-PGA) nanoparticles (Nps) and evaluates the in vitro/in vivo effects on EGFR-overexpressing gastric cancer cells (MKN-28). Nontargeted DOCT-γ-PGA Nps (NT Nps: 110±40 nm) and targeted CET MAb-DOCT-γ-PGA Nps (T Nps: 200±20 nm) were prepared using ionic gelation followed by 1-Ethyl-3-(3-dimethyl aminopropyl)carbodiimide-N-Hydoxysuccinimide (EDC-NSH) chemistry. Increased uptake correlated with enhanced cytotoxicity induced by targeted Nps to EGFR +ve MKN-28 compared with nontargeted Nps as evident from MTT and flow cytometric assays. Nanoformulated DOCT showed a superior pharmacokinetic profile to that of free DOCT in Swiss albino mice, indicating the possibility of improved therapeutic effect in the disease model. Qualitative in vivo imaging showed early and enhanced tumor targeted accumulation of CET MAb-DOCT-γ-PGA Nps in EGFR +ve MKN-28-based gastric cancer xenograft, which exhibited efficient arrest of tumor growth compared with nontargeted Nps and free DOCT. Thus, actively targeted CET MAb-DOCT-γ-PGA Nps could be developed as a substitute to conventional nonspecific chemotherapy, and hence could become a feasible strategy for cancer therapy for EGFR-overexpressing gastric tumors.

Authors : Sreeranganathan Maya , Uthaman Saji , Sarmento Bruno , Mohan Chethampadi Gopi , Park In-Kyu , Jayakumar Rangasamy ,

Related products :

Catalog number Product name Quantity
25513-46-6 Poly-(L-glutamic acid) Poly-L-glutamic acid 1g
A1047-100 Anti-EGFR (Cetuximab), Chimeric Antibody 50
P21760 Poly-L-glutamic acid 15-50,000 MW 100 MG
P21760 Poly-L-glutamic acid 15-50,000 MW 25 MG
KP1393 Poly -γ- D - Glutamic Acid Construct 1 mg
AP-313-B Human Breast Cancer Xenografts (RGD-4C), Peptide Aptamer, Biotinylated 1 mg
AP-313-U Human Breast Cancer Xenografts (RGD-4C), Peptide Aptamer, Unlabelled 5 mg
26247-79-0 Poly-(L-glutamic acid sodium) MW larger than 50,000 1g
AP-313-F Human Breast Cancer Xenografts (RGD-4C), Peptide Aptamer, FITC labelled 1 mg
AP-313-B Human Breast Cancer Xenografts (RGD-4C), Peptide Aptamer, Biotinylated Species Reactivity: 1 mg Product tipe: Peptide Aptamers
AP-313-U Human Breast Cancer Xenografts (RGD-4C), Peptide Aptamer, Unlabelled Species Reactivity: 5 mg Product tipe: Peptide Aptamers
AP-313-F Human Breast Cancer Xenografts (RGD-4C), Peptide Aptamer, FITC labelled Species Reactivity: 1 mg Product tipe: Peptide Aptamers
5-81011 Human gastric smooth muscle cells (tumor), male, 70, gastric cancer vial
orb71606 Pig Gastric Inhibitory Poly (1-30) peptide This is Pig Gastric Inhibitory Poly (1-30) peptide. For research use only. 1 mg
ISTMC-SER Cancer samples: Gastric Carcinoma Cancer Serum Each
ISTMC-N Cancer Samples: Gastric Carcinoma Cancer Plasma Each
orb71607 Human Gastric Inhibitory Poly (6-30) peptide This is Human Gastric Inhibitory Poly (6-30) peptide. For research use only. 1 mg
GI_Stomach - STC481 Stomach cancer tissue array, 16 cases of gastric cancer, each in duplicates, paired with corresponding uninvolved tissues from the same patients 2mm
25-160 TIPARP is a poly [ADP-ribose] polymerase using NAD+ as a substrate to transfer ADP-ribose onto glutamic acid residues of a protein acceptor; repeated rounds of ADP-ribosylation leads to the formation 0.05 mg
5891-45-2 N-S-Cbz-L-glutamic acid S-benzyl ester N-S-Cbz-L-glutamic aci 1g
orb61325 Docetaxel Docetaxel, a semisynthetic analog of paclitaxel, shares the latter's mechanism of action For research use only. 300 mg
PY-10034 Cancer and metastasis related antibodies : Anti-Breast cancer 1(BRCA1),Chicken-Poly 100μg
15-288-22030F SH3 domain-binding glutamic acid-rich protein - SH3BGR protein; 21-glutamic acid-rich protein; 21-GARP Polyclonal 0.1 mg
15-288-22030F SH3 domain-binding glutamic acid-rich protein - SH3BGR protein; 21-glutamic acid-rich protein; 21-GARP Polyclonal 0.05 mg
10-288-22030F SH3 domain-binding glutamic acid-rich protein - SH3BGR protein; 21-glutamic acid-rich protein; 21-GARP 0.05 mg


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur